EU helps Georgian biotech company reduce the use of antibiotics in meat production
May 31, 2021

EU helps Georgian biotech company reduce the use of antibiotics in meat production

The EU and FAO have awarded a matching grant of US$150,000 to Biochimpharm, a Georgian biotech company that gained worldwide recognition producing bacteriophages. The funding will support ‘PowerPhage’ production, a bacteriophage, natural antimicrobial veterinary solution, which reduces the use of antibiotics in meat production, with a focus on poultry farms.

The EU and FAO grant is expected to create new jobs and help the company grasp its tremendous export potential on the EU market. It is a part of a total US$1,000,000 investment, raised by the company, aimed to allow a 300% increase in PowerPhage production.

The EU is supporting agriculture and rural development in Georgia through its ENPARD programme. Implemented since 2013 with a total budget of €234.5 million, the main goal of ENPARD is to provide economic opportunities in rural areas and reduce poverty in Georgia.

Find out more

Press release


Interested in the latest news and opportunities?

This website is managed by the EU-funded Regional Communication Programme for the Eastern Neighbourhood ('EU NEIGHBOURS east’), which complements and supports the communication of the Delegations of the European Union in the Eastern partner countries, and works under the guidance of the European Commission’s Directorate-General for Neighbourhood Policy and Enlargement Negotiations, and the European External Action Service. EU NEIGHBOURS east is implemented by a GOPA PACE-led consortium. It is part of the larger Neighbourhood Communication Programme (2020-2024) for the EU's Eastern and Southern Neighbourhood, which also includes 'EU NEIGHBOURS south’ project that runs the EU Neighbours portal.

The information on this site is subject to a Disclaimer and Protection of personal data. © European Union,